Classification of normogonadotropic infertility: polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of polycystic ovary syndrome
Fertility and SterilityPublished 1 March 1997Open access
Evert J. P. van Santbrink, Wim C.J. Hop, Bart C.J.M. Fauser
Citations193
SJR quartileQ1
SJR score2.03
SNIP2.05
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
In the study group of normogonadotropic oligomenorrhea or amenorrheic infertile women, strict cutoff levels for various criteria used in the literature for defining PCOS were set, but sonographic parameters had limited predictive value for abnormal hormone serum levels.
Abstract
In the study group of normogonadotropic oligomenorrhea or amenorrheic infertile women, we set strict cutoff levels for various criteria used in the literature for defining PCOS. Groups defined by sonographic or endocrine PCOS criteria did overlap, but sonographic parameters had limited predictive value for abnormal hormone serum levels.
Keywords
Medicine
Human ReproductionAndrology: Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients
1,034 Citations1995A H Balen, Gerard S. Conway +5 more
Describing data from the largest reported series of women with PCOS enables the development of a management-orientated approach to the syndrome.
The LancetPOLYCYSTIC OVARIES—A COMMON FINDING IN NORMAL WOMEN
916 Citations1988D. W. POLSON, J Wadsworth +2 more
The prevalence of polycystic ovaries (PCO) in normal women of reproductive age was determined by pelvic ultrasound scanning of 257 volunteers who considered themselves to be normal and who had not sought treatment for menstrual disturbances, infertility, or hirsutism, which suggest that PCO in women who consider themselves toBe normal is part of the same clinical spectrum as the classic Stein-Leventhal syndrome.
The LancetMULTIFOLLICULAR OVARIES: CLINICAL AND ENDOCRINE FEATURES AND RESPONSE TO PULSATILE GONADOTROPIN RELEASING HORMONE
807 Citations1985Judith Adams, D. W. POLSON +7 more
Australian and New Zealand Journal of Obstetrics and GynaecologyThe Prevalence of Polycystic Ovaries on Ultrasound Scanning in a Population of Randomly Selected Women
252 Citations1994Cindy Farquhar, Mary Birdsall +3 more
No differences existed between women with PCO and normal ovaries with respect to uterine size, body mass index, luteinizing hormone levels, serum hormone binding globulin levels and fertility status, but hirsutism, elevated testosterone levels and irregular menstrual cycles were significantly more frequent amongst women withPCO.
Clinics in Obstetrics and GynaecologyOvulatory Disorders in Women with Polycystic Ovary Syndrome
208 Citations1985Stephen Franks, Judith Adams +2 more
Of the medical methods of ovulation induction in clomiphene non-responders, two methods have emerged as being highly promising: the first is administration of HMG following suppression of the pituitary by an LH-RH analogue and the second is low-dose FSH.
Fertility and SterilityDecremental follicle-stimulating hormone and dominant follicle development during the normal menstrual cycle
196 Citations1995Evert J. P. van Santbrink, Wim C.J. Hop +3 more
It is suggested that even in women exhibiting normal ovarian function a 2.5-fold difference in FSH threshold concentrations for follicle recruitment does occur and the magnitude of decrease in serum FSH concentrations during the follicular phase affects dominant follicle E2 production.
RadiologyGray-Scale Ultrasonography of the Normal Female Pelvis
185 Citations1977W. Frederick Sample, Barbara M. Lippe +1 more
The pelvis was evaluated with gray-scale ultrasound in 45 normal females, important aspects of instrumentation, changes in scanning techniques, and pitfalls in the identification of various normal anatomical structures are described, and normal ranges of uterine size and ovarian volume are reported.
The Journal of Clinical Endocrinology & MetabolismSerum Bioactive and Immunoreactive Luteinizing Hormone and Follicle-Stimulating Hormone Levels in Women with Cycle Abnormalities, with or without Polycystic Ovarian Disease*
169 Citations1991Bart C.J.M. Fauser, Thierry D. Pache +4 more
Serum steroid, gonadotropin, and alpha-subunit levels were assessed in 35 women with cycle abnormalities and 8 regularly cycling women in the early (cycle day 3 or 4) and mid ( cycle day 7 or 8) follicular phase of control cycles and non-PCOD patients.
Clinical EndocrinologyThe diagnosis of polycystic ovaries in women with oligo‐amenorrhoea: predictive power of endocrine tests
144 Citations1991Robert Fox, Elizabeth Corrigan +2 more
Assessment of oestrogen state is a useful method for categorizing patients with functional oligo‐amenorrhoea using ultrasonography as a reference test given the limited availability of the assay for SHBG.
Fertility and SterilityAssociation between ovarian changes assessed by transvaginal sonography and clinical and endocrine signs of the polycystic ovary syndrome
114 Citations1993Thierry D. Pache, Frank H. de Jong +2 more
Although immunoreactive LH and bioactive LH correlated with all ovarian parameters, the effect of androgens on ovarian changes appeared to be independent from LH, which further substantiates the apparent cardinal role of androgen in the genesis of polycystic ovaries.
Clinical EndocrinologyOvarian stromal hypertrophy in hyperandrogenic women
109 Citations1994Didier Dewailly, Yann Robert +5 more
The use of computer assisted analysis of ultrasound scans is evaluated to provide more objective measurements of ovarian structure and size.
Fertility and SterilityElevated bioactive luteinizing hormone in women with the polycystic ovary syndrome
109 Citations1983Rogerio A. Løbo, Oscar A. Kletzky +2 more
Fertility and SterilityPolycystic ovarian disease: contribution of vaginal endosonography and reassessment of ultrasonic diagnosis
105 Citations1991Yves Ardaens, Yann Robert +3 more
An increased ovarian stroma seems to be the most sensitive and specific US sign of PCOD, providing that it can be investigated by vaginal US.
BJOG An International Journal of Obstetrics & GynaecologyWhich hormone tests for the diagnosis of polycystic ovary syndrome?
99 Citations1992Stuart A. Robinson, D. A. Rodin +3 more
The frequency of abnormal values for hormone measurements commonly used in the biochemical diagnosis of polycystic ovary syndrome (PCOS) are assessed.
Human ReproductionImplications of ultrasonically diagnosed polycystic ovaries. I. Correlations with basal hormonal profiles
72 Citations1992Ahmed Abdel Gadir, Mohamed S. Khatim +4 more
Ulasonic diagnosis of PCO should be supplemented with an endocrine biochemical assessment to prevent overdiagnosis of PCOD and to exclude other endocrine dysfunctions.
Ultrasound in Medicine & BiologyTransvaginal sonography and abnormal ovarian appearance in menstrual cycle disturbances
65 Citations1991Thierry D. Pache, Wim C.J. Hop +3 more
Ovary changes and potential correlations with clinical and some biochemical features of polycystic ovarian syndrome (PCOS) are described and the usefulness of transvaginal sonography is validated in demonstrating numerous correlations in menstrual cycle disturbances.
American Journal of Obstetrics and GynecologyCorrelation of the ultrasonic appearance of the ovaries in polycystic ovarian disease and the clinical, hormonal, and laparoscopic findings
42 Citations1986Gamal H. el Tabbakh, Ibrahim Lotfy +4 more
Clinical EndocrinologyThe significance of a single serum LH measurement in women with cycle disturbances: discrepancies between immunoreactive and bioactive hormone estimates*
39 Citations1992Bart C.J.M. Fauser, Thierry D. Pache +3 more
The significance of single serum LH estimates and Leydig cell in‐vitro bioassay for the diagnosis of polycystic ovary syndrome (PCOS) in women with infertility and cycle abnormalities is evaluated.
Human ReproductionThe effects of a gonadotrophin-releasing hormone agonist on treatment with low dose follicle stimulating hormone in polycystic ovary syndrome
36 Citations1993Fedde Scheele, Peter G.A. Hompes +3 more
It is concluded that during the use of GnRHa, stimulation with low dose FSH less frequently resulted in monofollicular growth, possibly due to postponed atresia, and the useof GnR Ha does not abolish the inter- and intra-individual variability of the FSH dose inducing ongoing follicular growth.
Human ReproductionMorphological assessment of polycystic ovary using transvaginal ultrasound
33 Citations1993Kentaro Takahashi, Yoshimi Eda +4 more
Screening the ovaries in infertile patients by means of transvaginal ultrasound and subsequent assessment of morphology in PCO may suggest endocrine abnormality and help in selecting the proper treatment.
Gynecological EndocrinologyOvarian enlargement as a possible marker of androgen activity in polycystic ovary syndrome
33 Citations1991Z. Puzigaić, Gordana M. Prelević +2 more
The results of this study allow us to suggest ovarian enlargement as a marker of excessive androgen production and disturbances of menstrual cycle in polycystic ovary syndrome.
Clinical EndocrinologyHORMONAL STUDIES ON WOMEN WITH POLYCYSTIC OVARIES DIAGNOSED BY ULTRASOUND
26 Citations1990M. Obhrai, S. S. LYNCH +4 more
There is a relationship between the degree of hormonal abnormality and the menstrual irregularities and hirsutism in women with PCOS suggesting that there may be a progressive nature to the syndrome.
Human ReproductionCytogenetic analysis of unfertilized oocytes retrieved after treatment with the LHRH analogue, buserelin
24 Citations1990Joy Delhanty, R. Penketh
Data suggest that follicular stimulation regimes which precede IVF do not necessarily add to the naturally high aneuploidy rate of the human species, providing no evidence that the improved pregnancy rate with buserelin is due to chromosomal factors.
Clinics in Obstetrics and GynaecologyDisturbances of Androgen Secretion and Metabotism in Polycystic Ovary Syndrome
22 Citations1985Rogerio A. Løbo
No matter how the authors define PCO, it is a heterogeneous clinical disorder and hirsute and nonhirsute patients with PCO may be differentiated by their degree of peripheral androgen metabolism, specifically by their serum levels of 3 alpha-diol G.